Vol. 14 No. 1 (2022): Archives of Public Health
Case Report

Ventricular fibrillation after endoscopic retrograde cholangiopancreatography in patient with left ventricular assist device – a case report

Antonio Georgiev
University Clinic of cardiology; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia
Hristo Pejkov
University Clinic of cardiology; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine , Republic of North Macedonia
Oliver Kalpak
University Clinic of cardiology; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine , Republic of North Macedonia
Marjan Bosev
University Clinic of cardiology; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine , Republic of North Macedonia
Filip Janusevski
University Clinic of cardiology; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine , Republic of North Macedonia
Marija Jovanovski Srceva
University Clinic for Traumatology, Orthopedic, Anesthesia, Reanimation and Intensive Care; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia
Nikola Gramatnikovski
University Clinic for Thoracic and Vascular Surgery; Ss. Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia

Published 2022-06-23

Keywords

  • LVAD,
  • ventricular fibrillation,
  • ECG,
  • ERCP,
  • blood pressure,
  • pulse,
  • survival
  • ...More
    Less

How to Cite

1.
Georgiev A, Pejkov H, Kalpak O, Bosev M, Janusevski F, Jovanovski Srceva M, Gramatnikovski N. Ventricular fibrillation after endoscopic retrograde cholangiopancreatography in patient with left ventricular assist device – a case report. Arch Pub Health [Internet]. 2022 Jun. 23 [cited 2022 Oct. 1];14(1). Available from: https://id-press.eu/aph/article/view/6047

Abstract

Congestive heart failure is a growing global health problem. Left ventricular assist device (LVAD) is a method used to extend the life of patients with congestive heart failure as a definitive treatment or to “bypass” the period until heart transplantation. Ventricular arrhythmias in patients with LVAD are not uncommon. The aim of this paper is to present the case of a patient with an already implanted LVAD and the need for appropriate interdisciplinary medical treatment. Case report: We present the case of a 54-year old patient, A. D., with implanted LVAD - HeartMate 3 due to severe congestive heart failure. The patient was admitted with jaundice at the PHIU Clinic for Gastroenterohepatology with performed endoscopic retrograde cholangiopancreatography (ERCP)) procedure and a stent was placed in the choledochus duct. Immeasurable blood pressure and pulse were recorded in this patient. The ECG was approaching VF (ventricular fibrillation) and it was all asymptomatic by the patient.  LVAD mechanical pump leads to continuous blood flow, which means that patients with LVAD not infrequently have no pulse or measurable blood pressure. Also, in patients with LVAD, ECG pulses are with electrical disturbances. VF and ventricular tachycardia (VT) are ventricular arrhythmias that are often seen on ECG in patients with implanted LVAD. Usually these arrhythmias occur with unknown duration and terminate spontaneously. Conclusion: Patients with LVAD are prone to cardiac arrhythmias. The continuous development of medical devices leads to a continuous educational and clinical approach to patients.                                                                        

Downloads

Download data is not yet available.

References

  1. Birati Е, Jeddup М. Left ventricular assist devices in the management of heart failure. Card Fail Rev 2015;1(1):25—30.
  2. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 2013;128:1810—1852.
  3. Howard J. E. Left ventricular assist devices (LVADS): history, clinical application and complications. Korean Circ J 2019;49(7):568—585.
  4. Copeland JG, Arabia FA, Tsau PH, Nolan PE, McClellan D, Smith RG, Slepian MJ. Total artificial hearts: bridge to transplantationCardiolClin 2003;21(1):101—13.
  5. Shashima Nakahara et al. Ventricular arrhythmias after ventricular assist device. Circulation: arrhythmia and electrophysiology 2013;6:648—654.
  6. Mehra MR, Uriel N, Naka Y, et al. MOMENTUM 3 Investigators. A fully magnetically levitated left ventricular assist device - final report. N Engl J Med 2019;380:1618—1627.
  7. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. The New England Journal of Medicine 2009;361(23):2241—2251.
  8. Drakos SG, Mehra MR. Clinical myocardial recovery during long-term mechanical support in advanced heart failure: insights into moving the field forward. J Heart Lung Transplant 2016;35:413—420.
  9. Potapov E, Antonides C, Crespo-Leiro M, Combes A, Färber G, Hannan M, Kukucka M, Jonge N, LoforteA, LundL,Mohacsil P, Morshuis M, Netukan I, Ozbaran M, Pappalardo F,Scandroglio A, Schweigerr M, Tsui S, Zimpfer D, Gustafsson F* (EACTS chairperson). 2019 EACTS expert consensus on long-term mechanical circulatory support. European Journal of Cardio-Thoracic Surgery2019;56(2):230—270.
  10. Salzberg S, Lachat M, Zund G, Turina M. Left ventricular assist device (LVAD) enables survival during 7h of sustained ventricular fibrillation. European journal of cardio-thoracic surgery 2004;26:444—446.
  11. Guglin M. Approach to unresponsive patient with LVAD. The VAD Journal 4. doi:https://doi.org/10.13023/VAD.2018.02.
  12. Mechanical circulatory support: A scientific statement from the American heart association. Circulation 2017;123(4).
  13. Poberdy at al. Cardiopulmonary resuscitation in adults and children with mechanical circulatory support. A scientific Statement from the American heart association. Circulation 2017;135e1115-e1134.